Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Ther Drug Monit. 2014 Apr;36(2):218–224. doi: 10.1097/FTD.0b013e3182a5c446

Figure 2.

Figure 2

Median (n=11) delta-9-tetrahydrocannabinol (THC) (A), 11-hydroxy-THC (11-OH-THC) (B) and 11-nor-9-carboxy-THC (THCCOOH) (C) plasma concentrations during 1st (D1) and 5th (D5) days of 0, 30, 60 and 120 mg/day dronabinol and a single smoked cannabis challenge. Arrows indicate dronabinol administration.